Statement of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 10,915	$ 5,484	$ 32,608	$ 13,386
General and administrative (including related party amounts of $173, $142, $570 and $260, respectively)	2,730	1,154	11,301	2,970
Total operating expenses	13,645	6,638	43,909	16,356
Loss from operations	(13,645)	(6,638)	(43,909)	(16,356)
Other income (expense):
Interest income	1,131	2	1,496	8
Other income (expense)	(5)	(7)	(17)	(16)
Total other income (expense)	1,136	(5)	1,479	(8)
Net loss and comprehensive loss	$ (12,509)	$ (6,643)	$ (42,430)	$ (16,364)
Net loss per share, basic	$ (0.30)	$ (0.72)	$ (1.02)	$ (3.63)
Net loss per share, diluted	$ (0.30)	$ (0.72)	$ (1.02)	$ (3.63)
Weighted average shares used to compute net loss per common share basic	41,997,195	9,164,003	41,777,052	4,504,997
Weighted average shares used to compute net loss per common share- diluted	41,997,195	9,164,003	41,777,052	4,504,997